The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Glucocorticoids (GC) and Interleukin-4 (IL-4) signaling pathways exhibit known interactions in lymphocytes.
• These interactions include inhibition of IL-4-mediated proliferation by dexamethasone and suppression of GC-induced apoptosis by IL-4.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying the reciprocal interference between GC and IL-4 signaling pathways.
• To investigate the functional consequences of the physical association between the GC receptor and STAT6.

Main Methods:

• Utilized murine CTLL-2 cells to study signaling pathway interactions.
• Assessed transactivation of the mouse mammary tumor virus (MMTV) promoter by GC.
• Examined transactivation of a STAT6-responsive promoter by IL-4.
• Investigated STAT6 DNA-binding activity.
• Performed co-immunoprecipitation to detect physical association between GC receptor and STAT6.

Main Results:

• IL-4 was found to inhibit GC-induced MMTV promoter transactivation in CTLL-2 cells.
• GC suppressed IL-4-induced transactivation of a STAT6-responsive promoter.
• GC did not affect IL-4-stimulated STAT6 DNA-binding.
• A physical association between the GC receptor and STAT6 was demonstrated.
• STAT6 overexpression enhanced the IL-4-mediated inhibition of GC-induced MMTV transactivation.

Conclusions:

• The molecular basis for reciprocal interference between IL-4 and GC signaling involves direct interaction between the GC receptor and STAT6.
• This interaction modulates the transcriptional activity of both signaling pathways.
• Findings provide insights into the complex interplay of immune and stress response signaling in lymphocytes.